#nasdaq

#nasdaq

Tech giants are facing scrutiny over the impacts of Trump's tariffs on their earnings and supply chains.

Investors are particularly focused on Apple's upcoming earnings report amid significant shifts in production strategy.

Economic data releases this week may further inform the market's reaction to trade policies.

Wall Street closed for trading to honor former President Jimmy Carter, marking a tradition of mourning deceased presidents that dates back to 1865.

Shopify is transitioning its U.S. listing from NYSE to Nasdaq while keeping its Toronto Stock Exchange listing unchanged.

The Nasdaq Composite Index and QQQ ETF recently hit all-time highs but face inflation concerns and historical precedents of valuation corrections.

Despite market volatility, Meta's strategic position makes it a compelling growth investment.

AppLovin, despite recent declines, presents a significant buying opportunity given its successful transition to an AI-driven adtech company.

Supermicro resolved its accounting issues and submitted its 10-K financial filing, avoiding potential NASDAQ delisting.

Supermicro's shares plunged over 30% following EY's resignation, heightening concerns over accounting irregularities and potential consequences including delisting from Nasdaq.

The Nasdaq is likely to continue climbing, supported by AI developments and projected economic impacts.

Nvidia's leadership in AI processing is crucial for market optimism and continued growth.

Tech earnings from giants like Alphabet fuel confidence in the Nasdaq, driving it to new highs.

Tech stocks plunged due to fears of new restrictions on semiconductor exports to China, impacting major chipmaking companies and chip-related stocks.

Options on the iShares Bitcoin Trust (IBIT) are anticipated to start trading on Nasdaq, attracting significant institutional interest in crypto investments.

Nasdaq proposes a transformative in-kind redemption model for Bitcoin ETFs, streamlining operations and reducing costs.

The Nasdaq is sharply down due to disappointing earnings guidance from major companies like Microsoft and Meta.

Tesla's surge drove the Nasdaq higher, while IBM's poor performance weighed down the Dow.

Mixed earnings results influenced investor sentiment across markets.

BioAge Labs Inc. is raising up to $157.5 million in its IPO targeting therapies for obesity and metabolic diseases.

The initial price range suggests a company market value of about $587 million.

Key investors include CEO Kristen Fortney and prominent venture capital firms.

Bithumb is reconsidering its initial public listing plans, now eyeing a Nasdaq listing instead of Kosdaq.